Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell CarcinomaChris Labaki, David A. Braun, Nourhan El Ahmar et al.|Journal of Clinical Oncology|2025Cited by 14
Characterization of the Cellular Origin and Oncogenic Mechanisms of Chromophobe Renal Cell Carcinoma (ChRCC) and Renal Oncocytic NeoplasmsChris Labaki, David A. Braun, Michel Alchoueiry et al.|The Oncologist|2023Cited by 2
Abstract B019: Clinical and molecular characterization of chromophobe renal cell carcinoma: A focus on immunotherapy based regimens and the tumor immune microenvironmentMichel Alchoueiry, Elizabeth P. Henske, Chris Labaki et al.|Cancer Research|2023Cited by 1
Cellular and molecular determinants of limited anti-tumor immunity in chromophobe renal carcinoma (ChRCC).Chris Labaki, David A. Braun, Michel Alchoueiry et al.|Journal of Clinical Oncology|2024Cited by 1
Molecular characterization of the tumor microenvironment in chromophobe renal cell carcinoma (ChRCC) and related oncocytic neoplasms.Chris Labaki, Toni K. Choueiri, Long Zhang et al.|Journal of Clinical Oncology|2022Cited by 0